Letter: the duration of a patient's long-term stability on anti-TNFs should be considered before nonmedical switching to a biosimilar.

Aliment Pharmacol Ther

Medical & Scientific Affairs, Janssen-Cilag, Sydney, NSW, Australia.

Published: June 2020

Download full-text PDF

Source
http://dx.doi.org/10.1111/apt.15705DOI Listing

Publication Analysis

Top Keywords

letter duration
4
duration patient's
4
patient's long-term
4
long-term stability
4
stability anti-tnfs
4
anti-tnfs considered
4
considered nonmedical
4
nonmedical switching
4
switching biosimilar
4
letter
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!